TEMT is an investigational device currently under clinical development and currently not available for purchase. NeuroEM’s Pivotal clinical trial is anticipated to begin enrollment in early 2021 at approximately 10-12 clinical trial locations (not yet determined) throughout the U.S. Please check this website or the company’s social media sites regularly for announcements regarding when the Pivotal clinical trial will begin and a listing of clinical trial locations. To register to receive clinical trial updates, please complete and submit the form on the right.

NeuroEM Therapeutics, Inc.

11811 N. Tatum Blvd.
Suite 3031
Phoenix, AZ 85028

  • This field is for validation purposes and should be left unchanged.